Infraredx raises more cash to back imaging system ramp-up

Infraredx's TVC Imaging System--Courtesy of Infraredx

Infraredx needs more cash to fuel the commercialization of its intravascular imaging system, and the Massachusetts company will be getting it from GE Capital. General Electric's ($GE) financial services arm has increased a senior secured credit facility to the company from $6.6 million to $20 million. In August, Infraredx brought in $25 million from equity investment partner Nipro to help advance the company's signature product in Japan. Infraredx expects to win Japanese approval for its TVC Imaging System by the first half of 2014, giving it access to the world's largest intravascular imaging market. Item

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.